Literature DB >> 10781515

Risk factors for proliferative vitreoretinopathy after primary vitrectomy: a prospective study.

C H Kon1, R H Asaria, N L Occleston, P T Khaw, G W Aylward.   

Abstract

AIM: To assess clinical variables and vitreous protein as risk factors for the development of postoperative proliferative vitreoretinopathy (PVR).
METHODS: A prospective study was conducted on 140 patients with a rhegmatogenous retinal detachment in whom a primary vitrectomy was performed. 12 clinical variables were recorded and vitreous samples obtained for measurement of protein concentration. Univariate and multivariate logistic regression analysis was used to determine the risk factors for PVR.
RESULTS: Complete data were available for 136 of 140 patients. 40 of the 136 patients (29.4%) developed postoperative PVR. Univariate regression revealed that significant (p<0.05) risk factors included aphakia, presence of preoperative PVR, size of detachment, the use of silicone oil, and high vitreous protein level. Multivariate regression analysis revealed only aphakia (odds ratio 2.72), the presence of preoperative PVR (odds ratio 3.01), and high vitreous protein concentration (odds ratio 1.11) to be significant (p<0.05) independent, predictive risk factors for the development of PVR.
CONCLUSIONS: This study has shown that the significant risk factors for PVR are preoperative PVR, aphakia, and high vitreous protein levels. Two models (clinical factors only and clinical factors and vitreous protein) were constructed to predict the probability of developing postoperative PVR and may be used to identify those at risk for possible intravitreal pharmacological treatment.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10781515      PMCID: PMC1723478          DOI: 10.1136/bjo.84.5.506

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  25 in total

1.  5-fluorouracil: new applications in complicated retinal detachment for an established antimetabolite.

Authors:  M Blumenkranz; E Hernandez; A Ophir; E W Norton
Journal:  Ophthalmology       Date:  1984-02       Impact factor: 12.079

2.  Clinical factors predisposing to massive proliferative vitreoretinopathy in rhegmatogenous retinal detachment.

Authors:  M Bonnet
Journal:  Ophthalmologica       Date:  1984       Impact factor: 3.250

3.  Blood-retinal barrier in eyes with long-standing aphakia with apparently normal fundi.

Authors:  K Miyake
Journal:  Arch Ophthalmol       Date:  1982-09

4.  Changing concepts of failures after retinal detachment surgery.

Authors:  W F Rachal; T C Burton
Journal:  Arch Ophthalmol       Date:  1979-03

5.  Massive preretinal retraction. A biomicroscopic study.

Authors:  F I Tolentino; C L Schepens; H M Freeman
Journal:  Arch Ophthalmol       Date:  1967-07

6.  The effect of oral 13-cis-retinoic acid on retinal redetachment after surgical repair in eyes with proliferative vitreoretinopathy.

Authors:  S Fekrat; E de Juan; P A Campochiaro
Journal:  Ophthalmology       Date:  1995-03       Impact factor: 12.079

7.  Clinical risk factors for proliferative vitreoretinopathy after retinal detachment surgery.

Authors:  P Girard; G Mimoun; I Karpouzas; G Montefiore
Journal:  Retina       Date:  1994       Impact factor: 4.256

Review 8.  [Clinical risk factors of vitreoretinal proliferations in rhegmatogenous retinal detachment].

Authors:  M Bonnet
Journal:  J Fr Ophtalmol       Date:  1994       Impact factor: 0.818

9.  Interleukin-1-beta changes the expression of metalloproteinases in the vitreous humor and induces membrane formation in eyes containing preexisting retinal holes.

Authors:  W Kosnosky; T H Li; V A Pakalnis; A Fox; R C Hunt
Journal:  Invest Ophthalmol Vis Sci       Date:  1994-12       Impact factor: 4.799

10.  Evaluation of toxicity and efficacy of a combination of antineoplastic agents in the prevention of PVR.

Authors:  M Salah-Eldin; G A Peyman; M el-Aswad; B Bandok; M M Bahgat; M R Niesman
Journal:  Int Ophthalmol       Date:  1994       Impact factor: 2.031

View more
  26 in total

Review 1.  Strategies to influence PVR development.

Authors:  Bernd Kirchhof
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-08-10       Impact factor: 3.117

2.  Nonsteroid anti-inflammatory therapy suppresses the development of proliferative vitreoretinopathy more effectively than a steroid one.

Authors:  Marina V Tikhonovich; Aleksei K Erdiakov; Svetlana A Gavrilova
Journal:  Int Ophthalmol       Date:  2017-06-21       Impact factor: 2.031

3.  Vitrectomy with scleral buckling versus with inferior retinectomy in treating primary rhegmatogenous retinal detachment with PVR and inferior breaks.

Authors:  Khaled G Abu Eleinen; Ahmed A Mohalhal; Dalia A Ghalwash; Ahmed A Abdel-Kader; Ahmed A Ghalwash; Islam A Mohalhal; Abdussalam M Abdullatif
Journal:  Eye (Lond)       Date:  2018-08-16       Impact factor: 3.775

4.  Primary vitrectomy for rhegmatogenous retinal detachment: an analysis of 512 cases.

Authors:  Heinrich Heimann; Xiulan Zou; Claudia Jandeck; Ulrich Kellner; Nikolaos E Bechrakis; Klaus-Martin Kreusel; Horst Helbig; Lothar Krause; Andreas Schüler; Norbert Bornfeld; Michael H Foerster
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-07-26       Impact factor: 3.117

Review 5.  Proliferative Vitreoretinopathy: A Review.

Authors:  Sana Idrees; Jayanth Sridhar; Ajay E Kuriyan
Journal:  Int Ophthalmol Clin       Date:  2019

6.  Primary rhegmatogenous retinal detachment: 20 years of change.

Authors:  M Minihan; V Tanner; T H Williamson
Journal:  Br J Ophthalmol       Date:  2001-05       Impact factor: 4.638

7.  The upregulation of zinc finger protein 670 and prostaglandin D2 synthase in proliferative vitreoretinopathy.

Authors:  Hsi-Kung Kuo; Yi-Hao Chen; Faye Huang; Yi-Chan Wu; Jentaie Shiea; Pei-Chang Wu
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-05-05       Impact factor: 3.117

8.  Non-buckled vitrectomy for retinal detachment with inferior breaks and proliferative vitreoretinophathy.

Authors:  Yan Sheng; Wen Sun; Bin Mo; Ya-Jie Yu; Yang-Shun Gu; Wu Liu
Journal:  Int J Ophthalmol       Date:  2012-10-18       Impact factor: 1.779

Review 9.  Recent perspectives on the delivery of biologics to back of the eye.

Authors:  Mary Joseph; Hoang M Trinh; Kishore Cholkar; Dhananjay Pal; Ashim K Mitra
Journal:  Expert Opin Drug Deliv       Date:  2016-09-06       Impact factor: 6.648

10.  Elevated proto-oncogene and collagen mRNA expression in PVR retinas.

Authors:  Margrit Hollborn; Frank Faude; Peter Wiedemann; Leon Kohen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-04-16       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.